Scinovex
review Open AccessTop 1% cited

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

The Journal of Clinical Endocrinology & Metabolism · 2011 · Vol. 96(2) · pp. 273–288
Шломо МелмедFelipe F. CasanuevaAndrew R. HoffmanDavid L. KleinbergVíctor M. MontoriJanet SchlechteJohn Wass

Abstract

Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented.

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsAdrenal and Paraganglionic TumorsGuidelineEndocrine systemMedicineGrading (engineering)Quality of evidenceClinical PracticeIntensive care medicineGynecologyInternal medicineFamily medicine

MeSH terms

AdultFemaleHumansHyperprolactinemiaPituitary NeoplasmsPregnancyProlactinomaEvidence-Based Medicine

Funding

  • U.S. Department of Defense
  • Eli Lilly and Company
  • Pfizer
  • Teva Pharmaceutical Industries
  • European Society of Endocrinology
  • Novo Nordisk
  • Ipsen
Citations
1,782
FWCI
46.30
field-weighted impact
References
146
Percentile
100%
vs. same field & year
Citations per year
Cited by
Menstrual disorders in chronic kidney disease: causes and management
International Journal of Clinical Obstetrics and Gynaecology · 2020 · 4 citations
Evaluation and Management of Testosterone Deficiency: AUA Guideline
The Journal of Urology · 2018 · 703 citations
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2013 · 1,858 citations
Related articles
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.